Enzymatically induced mineralization of platelet-rich fibrin

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 5, 2012, Pages 1335-1346

  Douglas, Timothy E L ^a,b   Gassling, Volker ^c   Declercq, Heidi A ^b   Purcz, Nicolai ^c   Pamula, Elzbieta ^d   Haugen, Hãvard J ^e   Chasan, Safak ^f   De Mulder, Eric L W ^a   Jansen, John A ^a   Leeuwenburgh, Sander C G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^e UNIVERSITY OF OSLO   (Norway)

^f MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

alkaline phosphatase; bone tissue engineering; hydrogel; mineralization; platelet rich fibrin

Indexed keywords

ALKALINE PHOSPHATASE; BONE REPLACEMENT; BONE TISSUE ENGINEERING; CALCIUM GLYCEROPHOSPHATE; CYTOCOMPATIBILITY; FTIR; FUNCTIONALIZATIONS; FUNCTIONALIZED; LIVE/DEAD STAINING; MASS FRACTION; MASS PERCENTAGE; MINERALIZATION; PLATELET-RICH FIBRIN; SAOS-2 CELLS; VON KOSSA STAINING;

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CALCIUM PHOSPHATE; HYDROGELS; PHOSPHATASES; PHOSPHOLIPIDS; PLATELETS; TISSUE ENGINEERING;

MINERALOGY;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; FIBRIN; GLYCEROPHOSPHATE CALCIUM; LACTATE DEHYDROGENASE; TETRAZOLIUM;

ARTICLE; BONE MINERALIZATION; CELL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; CYTOLOGY; DRUG ACTIVITY; ENZYME ACTIVITY; FRACTIONATION; FREEZE DRYING; GRAVITY; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEL; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY; STAINING; THERMODYNAMICS; THROMBOCYTE;

ALKALINE PHOSPHATASE; ANIMALS; BLOOD PLATELETS; CALCIFICATION, PHYSIOLOGIC; CATTLE; CELL DEATH; CELL LINE, TUMOR; FIBRIN; FREEZE DRYING; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; SPECTROMETRY, X-RAY EMISSION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAINING AND LABELING; THERMOGRAVIMETRY;

EID: 84859111362     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34073     Document Type: Article

References (56)

1. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM,. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 299-303. (Pubitemid 43303798)
2. Charrier JB, Monteil JP, Albert S, Collon S, Bobin S, Dohan Ehrenfest DM,. Relevance of Choukroun's platelet-rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: A new technique. Rev Laryngol Otol Rhinol 2008; 129: 313-318.
3. Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM,. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: A radiologic and histologic study at 6 months. J Periodontol 2009; 80: 2056-2064.
4. Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM,. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: Implant surgery, prosthodontics, and survival. Implant Dent 2009; 18: 220-229.
5. Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM,. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: A new grafting protocol. Implant Dent 2009; 18: 102-111.
6. Braccini F, Tardivet L, Dohan Ehrenfest DM,. [The relevance of Choukroun's Platelet-Rich Fibrin (PRF) during middle ear surgery: Preliminary results]. Rev Laryngol Otol Rhinol 2009; 130: 175-180.
7. Jang ES, Park JW, Kweon H, Lee KG, Kang SW, Baek DH, Choi JY, Kim SG,. Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich fibrin and silk fibroin powder combination graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 831-836.
8. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B,. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: e37-e44. (Pubitemid 43303801)
9. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G,. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009; 27: 63-69.
10. He L, Lin Y, Hu X, Zhang Y, Wu H,. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 707-713.
11. Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM,. [Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty?]. Rev Laryngol Otol Rhinol 2007; 128: 27-32. (Pubitemid 46918418)
12. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB,. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 341-352.
13. Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB,. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol 2010; 55: 185-194.
14. Rowlands AS, George PA, Cooper-White JJ,. Directing osteogenic and myogenic differentiation of MSCs: Interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol 2008; 295: C1037-C1044.
15. Evans ND, Minelli C, Gentleman E, LaPointe V, Patankar SN, Kallivretaki M, Chen X, Roberts CJ, Stevens MM,. Substrate stiffness affects early differentiation events in embryonic stem cells. Eur Cell Mater 2009; 18: 1-13; discussion 13-14.
16. Boyan BD, Lossdorfer S, Wang L, Zhao G, Lohmann CH, Cochran DL, Schwartz Z,. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater 2003; 6: 22-27. (Pubitemid 38851419)
17. Le Nihouannen D, Saffarzadeh A, Gauthier O, Moreau F, Pilet P, Spaethe R, Layrolle P, Daculsi G,. Bone tissue formation in sheep muscles induced by a biphasic calcium phosphate ceramic and fibrin glue composite. J Mater Sci Mater Med 2008; 19: 667-675. (Pubitemid 351244034)
18. Filmon R, Basle MF, Atmani H, Chappard D,. Adherence of osteoblast-like cells on calcospherites developed on a biomaterial combining poly(2-hydroxyethyl) methacrylate and alkaline phosphatase. Bone 2002; 30: 152-158. (Pubitemid 34044313)
19. Filmon R, Basle MF, Barbier A, Chappard D,. Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: A composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process. J Biomater Sci Polym Ed 2000; 11: 849-868. (Pubitemid 32058695)
20. Filmon R, Basle M. F, Barbier A, Chappard D,. [In vitro study of the effect of bisphosphonates on mineralization induced by a composite material: Poly 2(hydroxyethyl) methacrylate coupled with alkaline phosphatase]. Morphologie 2000; 84: 3-33.
21. Beertsen W, van den Bos T,. Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat. J Clin Invest 1992; 89: 1974-1980.
22. Yamauchi K, Goda T, Takeuchi N, Einaga H, Tanabe T,. Preparation of collagen/calcium phosphate multilayer sheet using enzymatic mineralization. Biomaterials 2004; 25: 5481-5489. (Pubitemid 38610186)
23. Spoerke ED, Anthony SG, Stupp SI,. Enzyme directed templating of artificial bone mineral. Adv Mater 2009; 21: 425-430.
24. Bruder SP, Caplan AI,. A monoclonal antibody against the surface of osteoblasts recognizes alkaline phosphatase isoenzymes in bone, liver, kidney, and intestine. Bone 1990; 11: 133-139. (Pubitemid 20226573)
25. Kang YH, Jeon SH, Park JY, Chung JH, Choung YH, Choung HW, Kim ES, Choung PH,. Platelet-rich fibrin is a Bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng Part A 2010; 17: 349-359.
26. Antoniades HN,. Human platelet-derived growth factor (PDGF): Purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci USA 1981; 78: 7314-7317. (Pubitemid 12186130)
27. Tischer E, Gospodarowicz D, Mitchell R, Silva M, Schilling J, Lau K, Crisp T, Fiddes JC, Abraham JA,. Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989; 165: 1198-1206. (Pubitemid 20029835)
28. Pfeilschifter J, Bonewald L, Mundy GR,. Characterization of the latent transforming growth factor beta complex in bone. J Bone Miner Res 1990; 5: 49-58. (Pubitemid 20089903)
29. Gassling V, Douglas T, Warnke PH, Acil Y, Wiltfang J, Becker ST,. Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clin Oral Implants Res 2010; 21: 543-549.
30. Gassling VL, Acil Y, Springer IN, Hubert N, Wiltfang J,. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 48-55.
31. Schouten C, van den Beucken JJ, de Jonge LT, Bronkhorst EM, Meijer GJ, Spauwen PH, Jansen JA,. The effect of alkaline phosphatase coated onto titanium alloys on bone responses in rats. Biomaterials 2009; 30: 6407-6417.
32. Brandl FP, Seitz AK, Tessmar JK, Blunk T, Göpferich AM,. Enzymatically degradable poly(ethylene glycol) based hydrogels for adipose tissue engineering. Biomaterials 2010; 31: 3957-3966.
33. Park H, Guo X, Temenoff JS, Tabata Y, Caplan AI, Kasper FK, Mikos AG,. Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabiit marrow mesenchymal stem cells. Biomacromolecules 2009; 10: 541-546.
34. Douglas T, Liu Q, Humpe A, Wiltfang J, Sivananthan S, Warnke PH,. Novel ceramic bone replacement material CeraBall seeded with human mesenchymal stem cells. Clin Oral Implants Res 2010; 21: 262-267.
35. Douglas T, Pamula E, Hauk D, Wiltfang J, Sivananthan S, Sherry E, Warnke PH,. Porous polymer/hydroxyapatite scaffolds: Characterization and biocompatibility investigations. J Mater Sci Mater Med 2009; 20: 1909-1915.
36. Warnke PH, Douglas T, Sivananthan S, Wiltfang J, Springer I, Becker ST,. Tissue engineering of periosteal cell membranes in vitro. Clin Oral Implants Res 2009; 20: 761-766.
37. Warnke PH, Douglas T, Wollny P, Sherry E, Steiner M, Galonska S, Becker ST, Springer IN, Wiltfang J, Sivananthan S,. Rapid prototyping: Porous titanium alloy scaffolds produced by selective laser melting for bone tissue engineering. Tissue Eng Part C Methods 2009; 15: 115-124.
38. Koutsopoulos S,. Synthesis and characterization of hydroxyapatite crystals: A review study on the analytical methods. J Biomed Mater Res 2002; 62: 600-612.
39. Orimo H,. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 2010; 77: 4-12.
40. de Jonge LT, van den Beucken JJ, Leeuwenburgh SC, Hamers AA, Wolke JG, Jansen JA,. In vitro responses to electrosprayed alkaline phosphatase/calcium phosphate composite coatings. Acta Biomater 2009; 5: 2773-2782.
41. Berendsen AD, Smit TH, Hoeben KA, Walboomers XF, Bronckers AL, Everts V,. Alkaline phosphatase-induced mineral deposition to anchor collagen fibrils to a solid surface. Biomaterials 2007; 28: 3530-3536. (Pubitemid 46830713)
42. Osathanon T, Giachelli CM, Somerman MJ,. Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials 2009; 30: 4513-4521.
43. Le Guehennec L, Goyenvalle E, Aguado E, Pilet P, Bagot D'Arc M, Bilban M, Spaethe R, Daculsi G,. MBCP biphasic calcium phosphate granules and tissucol fibrin sealant in rabbit femoral defects: The effect of fibrin on bone ingrowth. J Mater Sci Mater Med 2005; 16: 29-35. (Pubitemid 40476214)
44. Le Guehennec L, Goyenvalle E, Aguado E, Pilet P, Spaethe R, Daculsi G,. Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combining biphasic calcium phosphate granules and fibrin sealant. J Mater Sci Mater Med 2007; 18: 1489-1495. (Pubitemid 47030209)
45. Le Guehennec L, Layrolle P, Daculsi G,. A review of bioceramics and fibrin sealant. Eur Cell Mater 2004; 8: 1-10; discussion 10-11.
46. Jegoux F, Goyenvalle E, Bagot D'arc M, Aguado E, Daculsi G,. In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant. Arch Orthop Trauma Surg 2005; 125: 153-159. (Pubitemid 41166839)
47. Saffarzadeh A, Gauthier O, Bilban M, Bagot D'Arc M, Daculsi G,. Comparison of two bone substitute biomaterials consisting of a mixture of fibrin sealant (Tisseel) and MBCP (TricOs) with an autograft in sinus lift surgery in sheep. Clin Oral Implants Res 2009; 20: 1133-1139.
48. Le Nihouannen D, Guehennec LL, Rouillon T, Pilet P, Bilban M, Layrolle P, Daculsi G,. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials 2006; 27: 2716-2722. (Pubitemid 43122075)
49. Banks E, Nakajima S, Shapiro LC, Tilevitz O,. Fibrous apatite on modified collagen. Science 1997; 198: 1164-1166.
50. Doi Y, Horiguchi T, Moriwaki Y, Kitago H, Kajimoto T, Iwayama Y,. Formation of apatite-collagen complexes. J Biomed Mater Res 1996; 31: 43-49. (Pubitemid 26125303)
51. Feng CF, Khor KA, Kwek SWK, Cheang P,. Thermally induced crystallization of amorphous calcium phosphate in plasma-spheroidised hydroxyapatite powders. Mater Lett 2000; 46: 229-233. (Pubitemid 32033593)
52. Van den Vreken NM, Pieters IY, Declercq HA, Cornelissen MJ, Verbeeck RM,. Characterization of calcium phosphate cements modified by addition of amorphous calcium phosphate. Acta Biomater 2010; 6: 617-625.
53. Durand B, Gao FB, Raff M,. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997; 6: 306-317. (Pubitemid 27049388)
54. Anh DJ, Eden A, Farley JR,. Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum. Clin Chim Acta 2001; 311: 137-148. (Pubitemid 32889699)
55. Valenzuela GJ, Munson LA, Tarbaux NM, Farley JR,. Time-dependent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem 1987; 33: 1801-1806. (Pubitemid 19097548)
56. Su CY, Kuo YP, Tseng YH, Su CH, Burnouf T,. In vitro release of growth factors from platelet-rich fibrin (PRF): A proposal to optimize the clinical applications of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 56-61.